• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Alto MSP ICD and Alto 2 MSP ICD

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall Alto MSP ICD and Alto 2 MSP ICD see related information
Date Initiated by Firm July 19, 2005
Date Posted September 24, 2005
Recall Status1 Terminated 3 on January 28, 2007
Recall Number Z-1598-05
Recall Event ID 32687
Product Classification Defibrillator, Implantable, Dual-Chamber - Product Code MRM
Product Alto MSP (model 617) and Alto 2 MSP (model 627) Implantable cardioverter Defibrillator. Ventricular antitachycardia pacing. Dual chamber arrhythmia detection. biventricular pacing. ELA medical 98, rue Maurice Amoux, 92120 Montrouge- FRANCE. These ICDs are designed to recognize and treat slow or fast Ventricular Tachycardia or Ventricular Fibrillation by continuously monitoring atrial and ventricular activity to identify persistent ventricular arrhythmias and to deliver appropriate therapies.
Code Information devices manufactured between April 2003 and August 2004. Model 617 serial numbers: 241XH059, 305XH005 and 305XH014.   Model 627 serial numbers: 330YA541, 348YA563, 348YA571,  348YA573, 348YA576, 350YA594, 407YA604, 407YA630,  407YA635, 407YA644, 411YA001, 411YA002, 411YA011,  411YA014, 411YA015, 411YA016 and 418YA029. 
Recalling Firm/
ela Medical Llc
2950 Xenium Ln N Ste 120
Plymouth MN 55441-2623
Manufacturer Reason
for Recall
Devices manufactured prior to August 2004 may experience premature battery depletion and/or extended charge times which may affect the device's ability to function.
FDA Determined
Cause 2
Action A Dear Doctor letter dated 07/20/05 was sent describing the issue and providing recommendation that physicians follow-up with patients every 3 months. Patients who have frequent episodes of ventricular fibrillation or are pacemaker dependend may require prophylactic explantation or more frequent visits. A list of affected serial numbers was provided to each physician.
Quantity in Commerce 20 total devices (3-model 617 & 17-model 627)
Distribution Nationwide. AZ, CA, FL, IL, KY, LA, MD, MI, MO, NC, NJ, NM, NY, OH, PA, SC, TN, TX, WA and WI.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.